Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/MERCK-CO-INC-13611/news/Merck-s-Investigational-NNRTI-Doravirine-Meets-Primary-Efficacy-Endpoint-of-Non-Inferiority-to-24814717/?utm_source=whatsapp&utm_medium=social&utm_campaign=share